Modulation by budesonide of DNA methylation and mRNA expression in mouse lung tumors

Biomarkers are being developed that can aid in the evaluation of cancer therapeutic and chemopreventive drugs. Two suggested biomarkers found in mouse lung tumors are DNA hypomethylation and alterations in mRNA expression of genes, such as 18S RNA, caspase 3, cyclin B2, cyclin E1, iNOS and survivin. Budesonide is very efficacious in preventing lung tumors in mice, so that its ability to modulate biomarkers in lung tumors was determined. Lung tumors were induced by vinyl carbamate in female strain A/J mice. Budesonide (2.0 mg/kg diet) was administered for 2, 7 and 21 days or for 14 days followed by a 7‐days' holding period prior to the killing of the mice at week 27. After 2 days of budesonide treatment, the size of the lung tumors was reduced. Tumor size continued to decrease during the 21 days of treatment. In the tumors, 2 days of treatment resulted in (i) increased methylation of DNA, reversing DNA hypomethylation, (ii) increased expression of 18S RNA and (iii) decreased mRNA expression of caspase 3, cyclin B2, cyclin E1, iNOS and survivin. Termination of budesonide treatment at 7 days prior to killing did not affect the size of the tumors, but did result in increased mRNA expression of the 5 genes, approaching the expression level in tumors from control mice. Hence, budesonide rapidly decreased the size of lung tumors, reversed DNA hypomethylation and modulated mRNA expression of genes; with the molecular alterations requiring continued treatment with the drug for maintenance. © 2006 Wiley‐Liss, Inc.

[1]  R. Lubet,et al.  CHEMOPREVENTION: MOUSE COLON AND LUNG TUMOR BIOASSAY AND MODULATION OF DNA METHYLATION AS A BIOMARKER , 2005, Experimental lung research.

[2]  T. Chevassut,et al.  Severe Global DNA Hypomethylation Blocks Differentiation and Induces Histone Hyperacetylation in Embryonic Stem Cells , 2004, Molecular and Cellular Biology.

[3]  J. Herman,et al.  The Clinical Application of Targeting Cancer through Histone Acetylation and Hypomethylation , 2004, Clinical Cancer Research.

[4]  M. You,et al.  Budesonide exerts its chemopreventive efficacy during mouse lung tumorigenesis by modulating gene expressions , 2004, Oncogene.

[5]  C. Banov.  The Role of Budesonide in Adults and Children with Mild‐to‐Moderate Persistent Asthma , 2004, The Journal of asthma : official journal of the Association for the Care of Asthma.

[6]  I. Pogribny,et al.  Methyl deficiency causes reduction of the methyl-CpG-binding protein, MeCP2, in rat liver. , 2003, Carcinogenesis.

[7]  V. Steele,et al.  Effect of chemopreventive agents on separate stages of progression of benzo[alpha]pyrene induced lung tumors in A/J mice. , 2003, Carcinogenesis.

[8]  M. You,et al.  Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice. , 2003, Cancer research.

[9]  B. Dunn.  Hypomethylation: One Side of a Larger Picture , 2003, Annals of the New York Academy of Sciences.

[10]  A. Feinberg,et al.  Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. , 2002, Cancer research.

[11]  A. Feinberg,et al.  DNA methylation and genomic imprinting: insights from cancer into epigenetic mechanisms. , 2002, Seminars in cancer biology.

[12]  V. Steele,et al.  Prevention of mouse lung tumors by budesonide and its modulation of biomarkers. , 2002, Carcinogenesis.

[13]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[14]  V. Steele,et al.  Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol. , 2000, Carcinogenesis.

[15]  V. Steele,et al.  Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. , 1997, Cancer research.

[16]  V. Steele,et al.  Prevention of mouse lung tumors and modulation of DNA methylation by combined treatment with budesonide and R115777 (ZarnestraMT). , 2007, Carcinogenesis.